Clinical Trial Update: Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients [Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 3 trial evaluating the efficacy and safety of pramipexole for moderate-to-severe idiopathic Restless …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Pramipexole (Mirapex) (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED